Conmed (CNMD) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $46.30 -1.45%
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $274 million versus the consensus estimate of $278.76 million.
GUIDANCE:
Conmed sees FY2022 EPS of $3.60-$3.85, versus the consensus of $3.74. Conmed sees FY2022 revenue of $1.075-1.125 billion, versus the consensus of $1.11 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- inTEST Corp (INTT) reported Q2 Revenue ; Offers Guidance
- Regal-Beloit (RBC) Tops Q1 EPS by 47c; offers guidance
- Bogota Financial Corp. (BSBK) Reports Q2 EPS of $0.06
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
